v3.26.1
Condensed Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain/(Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   60,860,838      
Beginning balance at Dec. 31, 2024 $ 304,081 $ 6 $ 1,013,806 $ 321 $ (710,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   525,345      
Issuance of common stock under benefit plans 498   498    
Stock-based compensation expense 8,913   8,913    
Net unrealized loss on short-term investments (162)     (162)  
Net loss (56,166)       (56,166)
Ending balance (in shares) at Mar. 31, 2025   61,386,183      
Ending balance at Mar. 31, 2025 257,164 $ 6 1,023,217 159 (766,218)
Beginning balance (in shares) at Dec. 31, 2024   60,860,838      
Beginning balance at Dec. 31, 2024 304,081 $ 6 1,013,806 321 (710,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net unrealized loss on short-term investments (322)        
Net loss (99,466)        
Ending balance (in shares) at Jun. 30, 2025   61,386,183      
Ending balance at Jun. 30, 2025 220,082 $ 6 1,029,595 (1) (809,518)
Beginning balance (in shares) at Mar. 31, 2025   61,386,183      
Beginning balance at Mar. 31, 2025 257,164 $ 6 1,023,217 159 (766,218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans 0        
Stock-based compensation expense 6,378   6,378    
Net unrealized loss on short-term investments (160)     (160)  
Net loss (43,300)       (43,300)
Ending balance (in shares) at Jun. 30, 2025   61,386,183      
Ending balance at Jun. 30, 2025 $ 220,082 $ 6 1,029,595 (1) (809,518)
Beginning balance (in shares) at Dec. 31, 2025 61,449,290 61,449,290      
Beginning balance at Dec. 31, 2025 $ 181,205 $ 6 1,040,610 (15) (859,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   465,279      
Issuance of common stock under benefit plans 74   74    
Stock-based compensation expense 4,254   4,254    
Net unrealized loss on short-term investments (326)     (326)  
Net loss (20,040)       (20,040)
Ending balance (in shares) at Mar. 31, 2026   61,914,569      
Ending balance at Mar. 31, 2026 $ 165,166 $ 6 1,044,937 (341) (879,436)
Beginning balance (in shares) at Dec. 31, 2025 61,449,290 61,449,290      
Beginning balance at Dec. 31, 2025 $ 181,205 $ 6 1,040,610 (15) (859,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net unrealized loss on short-term investments (382)        
Net loss $ (42,411)        
Ending balance (in shares) at Jun. 30, 2026 61,920,154 61,920,154      
Ending balance at Jun. 30, 2026 $ 146,926 $ 6 1,049,124 (397) (901,807)
Beginning balance (in shares) at Mar. 31, 2026   61,914,569      
Beginning balance at Mar. 31, 2026 165,166 $ 6 1,044,937 (341) (879,436)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   5,585      
Issuance of common stock under benefit plans 0        
Stock-based compensation expense 4,187   4,187    
Net unrealized loss on short-term investments (56)     (56)  
Net loss $ (22,371)       (22,371)
Ending balance (in shares) at Jun. 30, 2026 61,920,154 61,920,154      
Ending balance at Jun. 30, 2026 $ 146,926 $ 6 $ 1,049,124 $ (397) $ (901,807)